focus -WSS

focus

author：focus 2025-10-01 17:09:17 - browse：27685

A new treatment for Alzheimer’s disease developed by Eli Lilly slowed patients’ rate of cognitive and functional decline by 35% compared to placebo, the company said Wednesday, paving the way for a submission to the Food and Drug Administration and boosting hopes for a new class of Alzheimer’s drugs.

But the positive outcome of the study involving the drug, called donanemab, could be tempered by the deaths of two patients, and possibly a third, from a type of brain swelling caused by these drugs.

The results of the study were reported in a press release and have not yet been reviewed by outside scientists. Lilly said the data will be used to file for full approval with the FDA before the end of June. If cleared, donanemab will compete with another new Alzheimer’s treatment, Leqembi, made by Eisai and Biogen, that secured FDA approval in January.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Medicare proposal to cover medical devices draws a mixed reaction
Next article： Scientists inch closer to single

WSS

Canadian Prime Minister Justin Trudeau separating from wife, Sophie

New guidelines on severe brain injury complicate already difficult decisions

Why drug prescriptions should include diagnoses

What is the Wagner Group? The 'brutal' Russian military unit in Ukraine

Physician groups backed by private equity giant lobby on mergers

Infectious disease expert Jeanne Marrazzo assumes Fauci role

explore

focus

hotspot

Activists slam private health insurers over coverage restrictions

CDC concerned about possible undetected monkeypox spread in U.K.

The high cost of giving birth even with insurance

New guidelines on severe brain injury complicate already difficult decisions

Wildfire smoke exposes gaps in outdoor worker protections

#NeedHerScience: shining a light on gender disparities in medicine

Heart attack and stroke risk calculators need revising

Mitch McConnell episode has important public health takeaway

State Dept. review finds Biden bears some blame for Afghanistan failures

Sage hopes for a blockbuster in antidepressant now before FDA

hotspot

What would happen to your eyes if you looked at the solar eclipse?

Mitch McConnell episode has important public health takeaway

Infectious disease expert Jeanne Marrazzo assumes Fauci role

No plane should take off without an EpiPen onboard

Sage hopes for a blockbuster in antidepressant now before FDA

Canadian Prime Minister Justin Trudeau separating from wife, Sophie

knowledge

entertainment

entertainment

knowledge